CA
NZ
UK
AU
IND
US
…
Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; CB-101 (Eczema Treatment) for atopic dermatitis (eczema); NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics. The company also provides vitiligo solutions and women's sexual wellness products. The company was incorporated in 2020 and is based in Fort Pierce, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Caring Brands, Inc. (NASDAQ: CABR) is limited and filings offer no clear description of operations. Major long-term growth drivers cannot be reliably identified. Investors may find potential upside if due diligence uncovers a scalable business model, credible management and improving financials, but these attributes are not apparent publicly.
Key investment risks include very limited disclosure, low trading liquidity, small-cap execution and financing risk, and potential regulatory, legal or operational uncertainties; investors should monitor SEC filings for material updates.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Income before tax | -6.28M | -1.52M | -0.13M |
| Net income | -6.28M | -1.52M | -0.13M |
| Selling general administrative | 0.15M | 0.72M | - |
| Gross profit | 0.00M | -0.00M | -0.10M |
| Reconciled depreciation | 0.30M | 0.15M | 0.00M |
| Ebit | -5.61M | - | - |
| Ebitda | -5.31M | - | - |
| Depreciation and amortization | 0.30M | - | - |
| Operating income | -5.94M | -1.53M | -0.15M |
| Other operating expenses | 5.94M | - | - |
| Interest expense | 0.02M | - | - |
| Net interest income | -0.02M | 0.01M | 0.00M |
| Total revenue | 0.00M | 0.00M | 0.02M |
| Total operating expenses | 5.94M | 1.53M | 0.17M |
| Cost of revenue | 0.00M | 0.00M | 0.12M |
| Total other income expense net | -0.34M | - | 0.02M |
| Net income from continuing ops | -6.28M | -1.52M | -0.13M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Total assets | 2.33M | 3.88M | 0.02M |
| Intangible assets | - | 2.85M | - |
| Other current assets | 0.12M | 0.04M | - |
| Total liab | 0.24M | 0.19M | 0.29M |
| Total stockholder equity | 2.09M | 3.69M | -0.27M |
| Other current liab | 0.01M | - | - |
| Common stock | 0.01M | - | - |
| Capital stock | 0.10M | 0.01M | 0.00M |
| Retained earnings | -7.14M | -0.86M | -0.27M |
| Cash | 2.19M | 0.47M | 0.02M |
| Total current liabilities | 0.18M | 0.19M | 0.02M |
| Net debt | -2.13M | - | 0.25M |
| Short long term debt total | 0.06M | - | - |
| Other stockholder equity | 9.22M | - | - |
| Total current assets | 2.33M | 0.53M | 0.02M |
| Long term investments | 0.00M | 0.50M | 0.00M |
| Net receivables | - | 0.00M | 0.00M |
| Long term debt | 0.06M | - | 0.27M |
| Inventory | 0.01M | 0.01M | 0.00M |
| Accounts payable | 0.17M | 0.17M | 0.02M |
| Non current assets total | 0.00M | 3.35M | 0.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Investments | - | - | 0.00M |
| Net borrowings | 0.17M | 0.67M | 0.02M |
| Total cash from financing activities | 3.41M | 0.67M | 0.02M |
| Net income | -6.28M | -1.52M | -0.13M |
| Change in cash | 1.72M | 0.45M | -0.00M |
| Begin period cash flow | 0.47M | 0.02M | 0.02M |
| End period cash flow | 2.19M | 0.47M | 0.02M |
| Total cash from operating activities | -1.69M | -0.82M | -0.06M |
| Issuance of capital stock | 3.24M | 0.00M | 0.00M |
| Depreciation | 0.30M | 0.15M | 0.00M |
| Change to inventory | 0.00M | 0.00M | 0.08M |
| Change to account receivables | 0.00M | 0.00M | 0.00M |
| Capital expenditures | 0.00M | 0.00M | 0.00M |
| Change in working capital | -0.18M | 0.14M | 0.09M |
| Stock based compensation | 1.24M | 0.40M | 0.00M |
| Other non cash items | 3.23M | - | - |
| Free cash flow | -1.69M | -0.82M | -0.06M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| CABR Caring Brands, Inc. Common Stock |
-0.02 1.80% |
1.09 | - | - | 4370.38 | 7.38 | 3154.52 |
| MKKGY Merck KGaA ADR |
0.17 0.53% |
32.25 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
161.82 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
-0.16 0.78% |
20.27 | - | 10.96 | 0.01 | 1.20 | 2.94 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
41.22 | - | 10.66 | 0.01 | 1.16 | 2.94 |
Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; CB-101 (Eczema Treatment) for atopic dermatitis (eczema); NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics. The company also provides vitiligo solutions and women's sexual wellness products. The company was incorporated in 2020 and is based in Fort Pierce, Florida.
130 S Indian River Drive, Fort Pierce, FL, United States, 34950
(561) 896-7616
4
| Name | Title | Year Born |
|---|---|---|
| Mr. Brian Scott John | Founder, Interim CFO & Chief Investment Officer, Principal Accounting Officer & Executive Chairman | 1969 |
| Dr. Glynn Wilson Ph.D. | CEO & Director | 1947 |
| Paul Jones | Operations Manager | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+1.59%
Communication Services
+0.05%
Consumer Cyclical
+0.14%
Consumer Defensive
-0.43%
Energy
-0.03%
Financial Services
+0.19%
Financials
-0.35%
Healthcare
+1.05%
Industrials
+0.67%
Real Estate
-0.25%
Technology
+1.31%
Utilities
+0.32%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...